Log in to save to my catalogue

In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model

In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5353687

In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model

About this item

Full title

In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model

Publisher

London: Nature Publishing Group UK

Journal title

Scientific reports, 2017-03, Vol.7 (1), p.44570-44570, Article 44570

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

Skeletal muscle tissue engineering holds great promise for pharmacological studies. Herein, we demonstrated an
in vitro
drug testing system using tissue-engineered skeletal muscle constructs. In response to epigenetic drugs, myotube differentiation of C2C12 myoblast cells was promoted in two-dimensional cell cultures, but the levels of contra...

Alternative Titles

Full title

In vitro drug testing based on contractile activity of C2C12 cells in an epigenetic drug model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5353687

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_5353687

Other Identifiers

ISSN

2045-2322

E-ISSN

2045-2322

DOI

10.1038/srep44570

How to access this item